RAS and RHO GTPases in G1-phase cell-cycle regulation (original) (raw)

• Sherr, C. J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60, 3689–3695 (2000).
  CAS PubMed Google Scholar
• Mulcahy, L. S., Smith, M. R. & Stacey, D. W. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313, 241–243 (1985). First demonstration of the essential role of RAS in mitogen-induced proliferation.
  Article CAS PubMed Google Scholar
• Stacey, D. W., Feig, L. A. & Gibbs, J. B. Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol. Cell. Biol. 11, 4053–4064 (1991).
  CAS PubMed PubMed Central Google Scholar
• Feramisco, J. R., Gross, M., Kamata, T., Rosenberg, M. & Sweet, R. W. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38, 109–117 (1984). Showed that the introduction of recombinant RAS protein is sufficient for the induction of proliferation.
  Article CAS PubMed Google Scholar
• Mittnacht, S., Paterson, H., Olson, M. F. & Marshall, C. J. Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein. Curr. Biol. 7, 219–221 (1997).
  Article CAS PubMed Google Scholar
• Peeper, D. S. et al. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386, 177–181 (1997). Along with reference 5, provides genetic evidence that inactivation of the retinoblastoma protein is a key function of RAS in cell-cycle regulation.
  Article CAS PubMed Google Scholar
• D'Abaco, G. M., Hooper, S., Paterson, H. & Marshall, C. J. Loss of Rb overrides the requirement for ERK activity for cell proliferation. J. Cell Sci. 115, 4607–4616 (2002).
  Article CAS PubMed Google Scholar
• Filmus, J. et al. Induction of cyclin D1 overexpression by activated ras. Oncogene 9, 3627–3633 (1994).
  CAS PubMed Google Scholar
• Hitomi, M. & Stacey, D. W. Cellular ras and cyclin D1 are required during different cell cycle periods in cycling NIH 3T3 cells. Mol. Cell. Biol. 19, 4623–4632 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Aktas, H., Cai, H. & Cooper, G. M. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol. 17, 3850–3857 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Albanese, C. et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589–23597 (1995).
  Article CAS PubMed Google Scholar
• Lavoie, J. N., L'Allemain, G., Brunet, A., Muller, R. & Pouyssegur, J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608–20616 (1996).
  Article CAS PubMed Google Scholar
• Winston, J. T., Coats, S. R., Wang, Y. Z. & Pledger, W. J. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12, 127–134 (1996).
  CAS PubMed Google Scholar
• Treinies, I., Paterson, H. F., Hooper, S., Wilson, R. & Marshall, C. J. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol. Cell. Biol. 19, 321–329 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Balmanno, K. & Cook, S. J. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18, 3085–3097 (1999).
  Article CAS PubMed Google Scholar
• Suzuki, T. et al. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev. 16, 1356–1370 (2002).
  Article PubMed PubMed Central CAS Google Scholar
• Gille, H. & Downward, J. Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem. 274, 22033–22040 (1999).
  Article CAS PubMed Google Scholar
• Diehl, J. A., Cheng, M., Roussel, M. F. & Sherr, C. J. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499–3511 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Muise-Helmericks, R. C. et al. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 273, 29864–29872 (1998).
  Article CAS PubMed Google Scholar
• Yu, Q., Geng, Y. & Sicinski, P. Specific protection against breast cancers by cyclin D1 ablation. Nature 411, 1017–1021 (2001).
  Article CAS PubMed Google Scholar
• Takuwa, N. & Takuwa, Y. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17, 5348–5358 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Weber, J. D., Hu, W., Jefcoat, S. C. Jr., Raben, D. M. & Baldassare, J. J. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J. Biol. Chem. 272, 32966–32971 (1997).
  Article CAS PubMed Google Scholar
• Delmas, C. et al. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells. J. Biol. Chem. 276, 34958–34965 (2001).
  Article CAS PubMed Google Scholar
• Rivard, N., Boucher, M. J., Asselin, C. & L'Allemain, G. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells. Am. J. Physiol. 277, C652–C664 (1999).
  Article CAS PubMed Google Scholar
• Vlach, J., Hennecke, S. & Amati, B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16, 5334–5344 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M. & Clurman, B. E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11, 1464–1478 (1997).
  CAS PubMed Google Scholar
• Malek, N. P. et al. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 413, 323–327 (2001).
  Article CAS PubMed Google Scholar
• Mamillapalli, R. et al. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2. Curr. Biol. 11, 263–267 (2001).
  Article CAS PubMed Google Scholar
• Medema, R. H., Kops, G. J., Bos, J. L. & Burgering, B. M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404, 782–787 (2000). Showed that RAS-induced transcriptional repression of p27 KIP1 occurs through the effects of AKT/PKB on forkhead transcription factors.
  Article CAS PubMed Google Scholar
• Kops, G. J. et al. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398, 630–634 (1999).
  Article CAS PubMed Google Scholar
• de Ruiter, N. D., Burgering, B. M. & Bos, J. L. Regulation of the Forkhead transcription factor AFX by Ral-dependent phosphorylation of threonines 447 and 451. Mol. Cell. Biol. 21, 8225–8235 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, Y., Martindale, J. L., Gorospe, M. & Holbrook, N. J. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res. 56, 31–35 (1996).
  CAS PubMed Google Scholar
• Bottazzi, M. E., Zhu, X., Bohmer, R. M. & Assoian, R. K. Regulation of p21cip1 expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J. Cell Biol. 146, 1255–1264 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• LaBaer, J. et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847–862 (1997).
  Article CAS PubMed Google Scholar
• Cheng, M. et al. The p21Cip1 and p27Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571–1583 (1999). Along with reference 34, describes the function of p21 and p27 as assembly factors for cyclin–CDK complexes.
  Article CAS PubMed PubMed Central Google Scholar
• Alt, J. R., Gladden, A. B. & Diehl, J. A. p21Cip1 Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J. Biol. Chem. 277, 8517–8523 (2002).
  Article CAS PubMed Google Scholar
• Rajasekhar, V. K. et al. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol. Cell 12, 889–901 (2003).
  Article CAS PubMed Google Scholar
• Hidalgo, M. & Rowinsky, E. K. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19, 6680–6686 (2000).
  Article CAS PubMed Google Scholar
• Hashemolhosseini, S. et al. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J. Biol. Chem. 273, 14424–14429 (1998).
  Article CAS PubMed Google Scholar
• Kawamata, S., Sakaida, H., Hori, T., Maeda, M. & Uchiyama, T. The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines. Blood 91, 561–569 (1998).
  Article CAS PubMed Google Scholar
• Nelsen, C. J., Rickheim, D. G., Tucker, M. M., Hansen, L. K. & Albrecht, J. H. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. J. Biol. Chem. 278, 3656–3663 (2003).
  Article CAS PubMed Google Scholar
• Nourse, J. et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570–573 (1994).
  Article CAS PubMed Google Scholar
• Jiang, H., Coleman, J., Miskimins, R. & Miskimins, W. K. Expression of constitutively active 4EBP-1 enhances p27Kip1 expression and inhibits proliferation of MCF7 breast cancer cells. Cancer Cell Int. 3, 2 (2003).
  Article PubMed PubMed Central Google Scholar
• Rousseau, D., Kaspar, R., Rosenwald, I., Gehrke, L. & Sonenberg, N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc. Natl Acad. Sci. USA 93, 1065–1070 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Lane, H. A., Fernandez, A., Lamb, N. J. & Thomas, G. p70S6K function is essential for G1 progression. Nature 363, 170–172 (1993). Demonstrated the crucial role of S6K, and therefore of the regulation of protein translation, in cell-cycle progression.
  Article CAS PubMed Google Scholar
• Dufner, A. & Thomas, G. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253, 100–109 (1999).
  Article CAS PubMed Google Scholar
• Kleijn, M., Scheper, G. C., Voorma, H. O. & Thomas, A. A. Regulation of translation initiation factors by signal transduction. Eur. J. Biochem. 253, 531–544 (1998).
  Article CAS PubMed Google Scholar
• Gao, X. & Pan, D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 15, 1383–1392 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Potter, C. J., Huang, H. & Xu, T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 105, 357–368 (2001).
  Article CAS PubMed Google Scholar
• Tapon, N., Ito, N., Dickson, B. J., Treisman, J. E. & Hariharan, I. K. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 105, 345–355 (2001). Together with references 48 and 49, revealed the roles of TSC1 and TSC2 in cell growth and proliferation.
  Article CAS PubMed Google Scholar
• Gao, X. et al. Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling. Nature Cell Biol. 4, 699–704 (2002).
  Article CAS PubMed Google Scholar
• Goncharova, E. A. et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem. 277, 30958–30967 (2002).
  Article CAS PubMed Google Scholar
• Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nature Cell Biol. 4, 648–657 (2002).
  Article CAS PubMed Google Scholar
• Jaeschke, A. et al. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J. Cell Biol. 159, 217–224 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Tee, A. R. et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl Acad. Sci. USA 99, 13571–13576 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. & Cantley, L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 10, 151–162 (2002). References 51–56, published in quick succession, establish the involvement of the TSC complex in the regulation of S6K through TOR.
  Article CAS PubMed Google Scholar
• Soucek, T., Yeung, R. S. & Hengstschlager, M. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl Acad. Sci. USA 95, 15653–15658 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Ito, N. & Rubin, G. M. gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 96, 529–539 (1999).
  Article CAS PubMed Google Scholar
• Benvenuto, G. et al. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 19, 6306–6316 (2000).
  Article CAS PubMed Google Scholar
• Herbert, T. P., Tee, A. R. & Proud, C. G. The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites. J. Biol. Chem. 277, 11591–11596 (2002).
  Article CAS PubMed Google Scholar
• von Manteuffel, S. R., Gingras, A. C., Ming, X. F., Sonenberg, N. & Thomas, G. 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. Proc. Natl Acad. Sci. USA 93, 4076–4080 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, T. A., Kong, X., Saltiel, A. R., Blackshear, P. J. & Lawrence, J. C. Jr. Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway. J. Biol. Chem. 270, 18531–18538 (1995).
  Article CAS PubMed Google Scholar
• Rolli-Derkinderen, M. et al. ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1. J. Biol. Chem. 278, 18859–18867 (2003).
  Article CAS PubMed Google Scholar
• Ming, X. F. et al. Activation of p70/p85 S6 kinase by a pathway independent of p21ras. Nature 371, 426–429 (1994).
  Article CAS PubMed Google Scholar
• Lehman, J. A., Calvo, V. & Gomez-Cambronero, J. Mechanism of ribosomal p70S6 kinase activation by granulocyte macrophage colony-stimulating factor in neutrophils: cooperation of a MEK-related, THR421/SER424 kinase and a rapamycin-sensitive, m-TOR-related THR389 kinase. J. Biol. Chem. 278, 28130–28138 (2003).
  Article CAS PubMed Google Scholar
• Martin, K. A., Schalm, S. S., Romanelli, A., Keon, K. L. & Blenis, J. Ribosomal S6 kinase 2 inhibition by a potent C-terminal repressor domain is relieved by mitogen-activated protein-extracellular signal-regulated kinase kinase-regulated phosphorylation. J. Biol. Chem. 276, 7892–7898 (2001).
  Article CAS PubMed Google Scholar
• Tee, A. R., Anjum, R. & Blenis, J. Inactivation of the tuberous sclerosis complex-1 and-2 gene products occurs by phosphoinositide 3-kinase (PI3K)/Akt-dependent and-independent phosphorylation of tuberin. J. Biol. Chem. 278, 37288–37296 (2003).
  Article CAS PubMed Google Scholar
• Basu, T. N. et al. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356, 713–715 (1992).
  Article CAS PubMed Google Scholar
• Engers, R. et al. Tiam1 mutations in human renal-cell carcinomas. Int. J. Cancer 88, 369–376 (2000).
  Article CAS PubMed Google Scholar
• The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305–1315 (1993).
• Wienecke, R., Konig, A. & DeClue, J. E. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J. Biol. Chem. 270, 16409–16414 (1995).
  Article CAS PubMed Google Scholar
• Xiao, G. H., Shoarinejad, F., Jin, F., Golemis, E. A. & Yeung, R. S. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J. Biol. Chem. 272, 6097–6100 (1997).
  Article CAS PubMed Google Scholar
• Castro, A. F., Rebhun, J. F., Clark, G. G. & Quilliam, L. A. Rheb binds TSC2 and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J. Biol. Chem. 278, 32493–32496 (2003).
  Article CAS PubMed Google Scholar
• Garami, A. et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11, 1457–1466 (2003).
  Article CAS PubMed Google Scholar
• Zhang, Y. et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nature Cell Biol. 5, 578–581 (2003).
  Article CAS PubMed Google Scholar
• Saucedo, L. J. et al. Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nature Cell Biol. 5, 566–571 (2003).
  Article CAS PubMed Google Scholar
• Stocker, H. et al. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nature Cell Biol. 5, 559–566 (2003). References 74–77 put RHEB into the pathway of TOR–S6K regulation by the TSC complex.
  Article CAS PubMed Google Scholar
• Yee, W. M. & Worley, P. F. Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals. Mol. Cell. Biol. 17, 921–933 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Gromov, P. S., Madsen, P. & Tomerup, N., Celis, J. E. A novel approach for expression cloning of small GTPases: identification, tissue distribution and chromosome mapping of the human homolog of rheb. FEBS Lett. 377, 221–226 (1995).
  Article CAS PubMed Google Scholar
• Mach, K. E., Furge, K. A. & Albright, C. F. Loss of Rhb1, a Rheb-related GTPase in fission yeast, causes growth arrest with a terminal phenotype similar to that caused by nitrogen starvation. Genetics 155, 611–622 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Patel, P. H. et al. Drosophila Rheb GTPase is required for cell cycle progression and cell growth. J. Cell Sci. 116, 3601–3610 (2003).
  Article CAS PubMed Google Scholar
• Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C. & Blenis, J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 1259–1268 (2003).
  Article CAS PubMed Google Scholar
• Inoki, K., Li, Y., Xu, T. & Guan, K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829–1834 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Dan, H. C. et al. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem. 277, 35364–35370 (2002).
  Article CAS PubMed Google Scholar
• Zhang, H., Stallock, J. P., Ng, J. C., Reinhard, C. & Neufeld, T. P. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14, 2712–2724 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Mak, B. C., Takemaru, K., Kenerson, H. L., Moon, R. T. & Yeung, R. S. The tuberin–hamartin complex negatively regulates β-catenin signaling activity. J. Biol. Chem. 278, 5947–5951 (2003).
  Article CAS PubMed Google Scholar
• Urano, T., Emkey, R. & Feig, L. A. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 15, 810–816 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• White, M. A., Vale, T., Camonis, J. H., Schaefer, E. & Wigler, M. H. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J. Biol. Chem. 271, 16439–16442 (1996). Along with reference 87, this paper revealed the crucial contribution of RAL in RAS signalling that leads to cell proliferation.
  Article CAS PubMed Google Scholar
• Rosario, M., Paterson, H. F. & Marshall, C. J. Activation of the Ral and phosphatidylinositol 3′ kinase signaling pathways by the ras-related protein TC21. Mol. Cell. Biol. 21, 3750–3762 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Henry, D. O. et al. Ral GTPases contribute to regulation of cyclin D1 through activation of NF-κB. Mol. Cell. Biol. 20, 8084–8092 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Chien, Y. & White, M. A. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 4, 800–806 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Self, A. J., Caron, E., Paterson, H. F. & Hall, A. Analysis of R-Ras signalling pathways. J. Cell Sci. 114, 1357–1366 (2001).
  Article CAS PubMed Google Scholar
• Rosario, M., Paterson, H. F. & Marshall, C. J. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. EMBO J. 18, 1270–1279 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Marte, B. M., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H. & Downward, J. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr. Biol. 7, 63–70 (1997).
  Article CAS PubMed Google Scholar
• Kimmelman, A. C., Osada, M. & Chan, A. M. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells. Oncogene 19, 2014–2022 (2000).
  Article CAS PubMed Google Scholar
• Graham, S. M. et al. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation. Mol. Cell. Biol. 14, 4108–4115 (1994).
  CAS PubMed PubMed Central Google Scholar
• Yamamoto, M. et al. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene 8, 1449–1455 (1993).
  CAS PubMed Google Scholar
• Olson, M. F., Ashworth, A. & Hall, A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269, 1270–1272 (1995). Along with reference 97, demonstrates the essential role of Rho GTPases in cell proliferation.
  Article CAS PubMed Google Scholar
• Olson, M. F., Paterson, H. F. & Marshall, C. J. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394, 295–299 (1998). Showed that Rho contributes to RAS-induced cell-cycle progression through repression of p21 CIP1.
  Article CAS PubMed Google Scholar
• Lloyd, A. C. et al. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11, 663–677 (1997).
  Article CAS PubMed Google Scholar
• Pumiglia, K. M. & Decker, S. J. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl Acad. Sci. USA 94, 448–452 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Sewing, A., Wiseman, B., Lloyd, A. C. & Land, H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. 17, 5588–5597 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Woods, D. et al. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17, 5598–5611 (1997). References 100–103 showed that the intensity of signalling through the Raf–MEK–ERK/MAPK pathway determines whether cells proliferate or undergo p21-mediated cell-cycle arrest.
  Article CAS PubMed PubMed Central Google Scholar
• Auer, K. L. et al. Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21 _Cip-1/WAF1_-null mice, but not in hepatocytes from p16 _INK4a_-null mice. Biochem. J. 336, 551–560 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Zuckerbraun, B. S., Shapiro, R. A., Billiar, T. R. & Tzeng, E. RhoA influences the nuclear localization of extracellular signal-regulated kinases to modulate p21Waf/Cip1 expression. Circulation 108, 876–881 (2003).
  Article CAS PubMed Google Scholar
• Lai, J. M., Wu, S., Huang, D. Y. & Chang, Z. F. Cytosolic retention of phosphorylated extracellular signal-regulated kinase and a Rho-associated kinase-mediated signal impair expression of p21(Cip1/Waf1) in phorbol 12-myristate-13-acetate-induced apoptotic cells. Mol. Cell. Biol. 22, 7581–7592 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Sahai, E., Ishizaki, T., Narumiya, S. & Treisman, R. Transformation mediated by RhoA requires activity of ROCK kinases. Curr. Biol. 9, 136–145 (1999).
  Article CAS PubMed Google Scholar
• Sahai, E., Olson, M. F. & Marshall, C. J. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 20, 755–766 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Roovers, K. & Assoian, R. K. Effects of rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G(1) phase cyclin-dependent kinases. Mol. Cell. Biol. 23, 4283–4294 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Noren, N. K., Niessen, C. M., Gumbiner, B. M. & Burridge, K. Cadherin engagement regulates Rho family GTPases. J. Biol. Chem. 276, 33305–33308 (2001).
  Article CAS PubMed Google Scholar
• Bao, W., Thullberg, M., Zhang, H., Onischenko, A. & Stromblad, S. Cell attachment to the extracellular matrix induces proteasomal degradation of p21CIP1 via Cdc42/Rac1 signaling. Mol. Cell. Biol. 22, 4587–4597 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hirai, A. et al. Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J. Biol. Chem. 272, 13–16 (1997).
  Article CAS PubMed Google Scholar
• Laufs, U., Marra, D., Node, K. & Liao, J. K. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1). J. Biol. Chem. 274, 21926–21931 (1999).
  Article CAS PubMed Google Scholar
• Hu, Z. Y., Madamanchi, N. R. & Rao, G. N. cAMP inhibits linoleic acid-induced growth by antagonizing p27kip1 depletion, but not interfering with the extracellular signal-regulated kinase or AP-1 activities. Biochim. Biophys. Acta 1405, 139–146 (1998).
  Article CAS PubMed Google Scholar
• Hu, W., Bellone, C. J. & Baldassare, J. J. RhoA stimulates p27Kip degradation through its regulation of cyclin E/CDK2 activity. J. Biol. Chem. 274, 3396–3401 (1999).
  Article CAS PubMed Google Scholar
• Adnane, J., Bizouarn, F. A., Qian, Y., Hamilton, A. D. & Sebti, S. M. p21WAF1/CIP1 is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor β- and Sp1- responsive element: involvement of the small GTPase rhoA. Mol. Cell. Biol. 18, 6962–6970 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Tanaka, T. et al. Activation of cyclin-dependent kinase 2 (Cdk2) in growth-stimulated rat astrocytes. Geranylgeranylated Rho small GTPase(s) are essential for the induction of cyclin E gene expression. J. Biol. Chem. 273, 26772–26778 (1998).
  Article CAS PubMed Google Scholar
• Vidal, A., Millard, S. S., Miller, J. P. & Koff, A. Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J. Biol. Chem. 277, 16433–16440 (2002).
  Article CAS PubMed Google Scholar
• Roovers, K., Davey, G., Zhu, X., Bottazzi, M. E. & Assoian, R. K. α5β1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol. Biol. Cell 10, 3197–3204 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Welsh, C. F. et al. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nature Cell Biol. 3, 950–957 (2001). Along with references 119 and 133, this paper revealed the contribution of integrin signalling through Rho GTPases to the elevation of cyclin-D1 levels.
  Article CAS PubMed Google Scholar
• Roovers, K., Klein, E. A., Castagnino, P. & Assoian, R. K. Nuclear translocation of LIM kinase mediates Rho–Rho kinase regulation of cyclin D1 expression. Dev. Cell 5, 273–284 (2003).
  Article CAS PubMed Google Scholar
• Joyce, D. et al. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-κB-dependent pathway. J. Biol. Chem. 274, 25245–25249 (1999).
  Article CAS PubMed Google Scholar
• Westwick, J. K. et al. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol. Cell. Biol. 17, 1324–1335 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Gjoerup, O., Lukas, J., Bartek, J. & Willumsen, B. M. Rac and Cdc42 are potent stimulators of E2F-dependent transcription capable of promoting retinoblastoma susceptibility gene product hyperphosphorylation. J. Biol. Chem. 273, 18812–18818 (1998).
  Article CAS PubMed Google Scholar
• Page, K. et al. Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J. Biol. Chem. 274, 22065–22071 (1999).
  Article CAS PubMed Google Scholar
• Cammarano, M. S. & Minden, A. Dbl and the Rho GTPases activate NFκB by IκB kinase (IKK)-dependent and IKK-independent pathways. J. Biol. Chem. 276, 25876–25882 (2001).
  Article CAS PubMed Google Scholar
• Murphy, G. A. et al. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth. Oncogene 18, 3831–3845 (1999).
  Article CAS PubMed Google Scholar
• Murphy, G. A. et al. Signaling mediated by the closely related mammalian Rho family GTPases TC10 and Cdc42 suggests distinct functional pathways. Cell Growth Differ. 12, 157–167 (2001).
  CAS PubMed Google Scholar
• Romanelli, A., Martin, K. A., Toker, A. & Blenis, J. p70 S6 kinase is regulated by protein kinase Cζ and participates in a phosphoinositide 3-kinase-regulated signalling complex. Mol. Cell. Biol. 19, 2921–2928 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Chou, M. M. & Blenis, J. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85, 573–583 (1996).
  Article CAS PubMed Google Scholar
• Lambert, J. M., Karnoub, A. E., Graves, L. M., Campbell, S. L. & Der, C. J. Role of MLK3-mediated activation of p70 S6 kinase in Rac1 transformation. J. Biol. Chem. 277, 4770–4777 (2002).
  Article CAS PubMed Google Scholar
• Chou, M. M., Masuda-Robens, J. M. & Gupta, M. L. Cdc42 promotes G1 progression through p70S6k-mediated induction of cyclin E expression. J. Biol. Chem. 278, 35241–35247 (2003).
  Article CAS PubMed Google Scholar
• Mettouchi, A. et al. Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol. Cell 8, 115–127 (2001).
  Article CAS PubMed Google Scholar
• Miyoshi, J., Kagimoto, M., Soeda, E. & Sakaki, Y. The human c-Ha-ras2 is a processed pseudogene inactivated by numerous base substitutions. Nucleic Acids Res. 12, 1821–1828 (1984).
  Article CAS PubMed PubMed Central Google Scholar
• Takahashi, K., Mitsui, K. & Yamanaka, S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423, 541–545 (2003).
  Article CAS PubMed Google Scholar
• Jirmanova, L., Afanassieff, M., Gobert-Gosse, S., Markossian, S. & Savatier, P. Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 21, 5515–5528 (2002).
  Article CAS PubMed Google Scholar